Barbara M Bröker Selected Research

Asthma (Bronchial Asthma)

1/2020	Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge.
1/2020	Mouse Strain-Dependent Difference Toward the Staphylococcus aureus Allergen Serine Protease-Like Protein D Reveals a Novel Regulator of IL-33.
1/2019	Nonatopic severe asthma might still be atopic: Sensitization toward Staphylococcus aureus enterotoxins.
1/2018	The IL-33/ST2 axis is crucial in type 2 airway responses induced by Staphylococcus aureus-derived serine protease-like protein D.
1/2017	Staphylococcal serine protease-like proteins are pacemakers of allergic airway reactions to Staphylococcus aureus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara M Bröker Research Topics

Disease

16	Sepsis (Septicemia) 01/2020 - 01/2005
9	Inflammation (Inflammations) 01/2021 - 11/2012
7	Peritonitis 01/2020 - 11/2010
6	Infections 01/2022 - 10/2015
5	Septic Shock (Toxic Shock Syndrome) 01/2023 - 07/2004
5	Asthma (Bronchial Asthma) 01/2020 - 01/2017
4	Stroke (Strokes) 08/2023 - 01/2010
4	Neoplasms (Cancer) 01/2021 - 12/2008
3	Pancreatitis 01/2022 - 01/2020
3	Hypersensitivity (Allergy) 01/2021 - 08/2018
3	Melanoma (Melanoma, Malignant) 01/2021 - 01/2015
3	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2011
3	Disease Progression 01/2017 - 01/2015
2	Rhinosinusitis 11/2023 - 01/2017
2	Nasal Polyps (Nasal Polyp) 11/2023 - 01/2017
2	COVID-19 09/2022 - 01/2021
2	Bacterial Infections (Bacterial Infection) 01/2019 - 01/2011
2	Bacteremia 01/2019 - 03/2011
2	Drug-Related Side Effects and Adverse Reactions 11/2012 - 01/2011
1	Body Weight (Weight, Body) 08/2023
1	Acute Necrotizing Pancreatitis 01/2023
1	Post-Acute COVID-19 Syndrome 09/2022
1	Muscular Atrophy (Muscle Atrophy) 01/2020
1	Atrophy 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Fistula 01/2019
1	Hyperplasia 01/2018
1	Eosinophilia 01/2018
1	Bronchial Hyperreactivity 01/2018
1	Endocarditis 01/2018
1	Ischemic Stroke 01/2017

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 11/2023 - 01/2005
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2015
8	AntigensIBA 09/2022 - 01/2011
6	SuperantigensIBA 01/2023 - 07/2004
5	Immunoglobulin G (IgG)IBA 09/2022 - 10/2015
4	AntibodiesIBA 09/2022 - 01/2011
4	VaccinesIBA 01/2021 - 10/2015
4	AllergensIBA 12/2020 - 01/2017
4	Enterotoxins (Enterotoxin)IBA 12/2020 - 07/2004
3	Immunoglobulins (Immunoglobulin)IBA 11/2023 - 01/2017
3	Immunoglobulin M (IgM)IBA 09/2022 - 01/2020
3	ChemokinesIBA 01/2022 - 01/2011
3	OvalbuminIBA 01/2021 - 01/2013
3	Serine Proteases (Serine Protease)IBA 01/2021 - 01/2018
3	Immunoglobulin E (IgE)IBA 12/2020 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 01/2010
2	EpitopesIBA 09/2022 - 01/2020
2	CeruletideIBA 12/2020 - 01/2020
2	Virulence Factors (Pathogenicity Factors)IBA 01/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2020
2	HLA-DR Antigens (HLA-DR)IBA 01/2020 - 01/2010
2	SteroidsIBA 01/2020 - 03/2014
2	Interleukin-33IBA 01/2020 - 01/2018
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 01/2018
2	TNF-Related Apoptosis-Inducing LigandIBA 01/2016 - 11/2010
2	Heparin (Liquaemin)FDA LinkGeneric 11/2012 - 01/2011
2	LigandsIBA 11/2010 - 12/2008
1	RNA (Ribonucleic Acid)IBA 11/2023
1	16S Ribosomal RNAIBA 01/2023
1	Staphylococcal enterotoxin FIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2022
1	ChAdOx1 nCoV-19IBA 01/2021
1	glutamyl endopeptidaseIBA 01/2021
1	aluminum sulfate (alum)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Monatide (IMS 3015)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	IpilimumabIBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	InterleukinsIBA 01/2020
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2020
1	InflammasomesIBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	AutoantigensIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Arginine (L-Arginine)FDA Link 01/2020
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	CaspasesIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	4(2'- aminoethyl)amino- 1,8- dimethylimidazo(1,2- a)quinoxalineIBA 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018

Therapy/Procedure

5	Ligation 12/2020 - 02/2012
5	Stents 01/2020 - 11/2010
4	Therapeutics 01/2017 - 12/2008
3	Punctures 01/2020 - 02/2012
1	Critical Care (Surgical Intensive Care) 09/2022
1	Injections 12/2020
1	Electrocoagulation (Electrocautery) 01/2020
1	Intraperitoneal Injections 01/2020
1	Central Venous Catheters 01/2019